Jak-STAT dysregulating pharmaceuticals are used to fight autoimmune disorders such as rheumatoid arthritis, ulcerative colitis, Crohn disease, myelofibrosis, polycythemia vera, and other myeloproliferative diseases (70, 71). This evidence concerns the gene SOAT1 and rheumatoid arthritis.